Form D · Other Health Care

ALVINE PHARMACEUTICALS INC

San Carlos, CA · CIK 0001374116

Offering snapshot reported Jan 3, 2013 · SEC filing

Reported sold
$6.01M
Offering amount: $6.51M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 19, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 3, 2013Initial$6,006,000No comparison7SEC filing
Oct 21, 2011Initial$6,006,000No comparison6SEC filing
Mar 10, 2011Amendment$26,500,000$17,999,996vs Sep 9, 200918SEC filing
Sep 9, 2009Initial$8,500,004No comparison16SEC filing
Aug 21, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-189318

Source: Form D, filed Jan 3, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Adelman Executive
Gaurav Aggarawal Director
L. Patrick Gage Director
Abhay Joshi Director, Executive
Chaitan Khosla Director
Nina Kjellson Director
Mike Powell Director
Michael Powell Director
William Ringo Director
Bill Ringo Director
David Schnell Director
David Southern Executive
James Watson Executive
Ilan Zipkin Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
75 Shoreway Road Suite B
San Carlos, CA, 94070